Risk of hyperglycaemia for diabetes patients using faulty insulin pensPeople with diabetes using insulin pens from a number of faulty batches manufactured by Owen Mumford are at risk of hyperglycaemia.…
Metformin shows promise as anti-tuberculosis drug A promising candidate in the search for alternative treatments for Mycobacterium tuberculosis is the antidiabetic drug metformin.…
Lloydspharmacy funds pilot project to improve care of patients after discharge from hospital Lloydspharmacy stores in Liverpool are set to pilot a new model of community pharmacy-based discharge care, as a result of a new research collaboration.…
Diabetes drugs show promise in Alzheimer’s disease Administration of glucagon-like peptide-1 (GLP-1) receptor agonists — which facilitate insulin signalling — has a neuroprotective effect in a mouse model of Alzheimer’s disease.…
Study upholds use of metformin monotherapy for first-line diabetes treatment Patients recently diagnosed with diabetes who are prescribed metformin monotherapy are less likely to require treatment intensification compared with patients prescribed other oral glucose-lowering medications as a monotherapy.…
Diabetic wounds heal faster with deferoxamine patch Researchers have developed a transdermal patch that delivers the small molecule deferoxamine to accelerate wound healing in diabetes.…
Mortality risk should be considered with choice of sulfonylurea drug Some sulfonylurea drugs, such as gliclazide and glimepiride, are associated with a lower mortality risk than others.…
Diabetes patients could be quizzed about driving habits during medication reviewsPeople with diabetes could be questioned about their driving habits as part of their medication review, under proposals contained in a report by the Transport Research Laboratory. …
Identifying patients at risk of diabetes With 11.5 million people at risk in the UK, it is essential to recognise the signs and symptoms of type 1 diabetes and type 2 diabetes.…
Canagliflozin and dapagliflozin interactions in diabetes treatment Find out which interactions are associated with the latest antidiabetic medicines.…